Performance Verification of Mechanistic Dermal Physiological Based Pharmacokinetic (PBPK) Model for Enhanced Understanding of Dermal Absorption: Prediction of Local Tissue Exposure after Topical Application of Acitretin October 8, 2018 By webdev
Extension of the Distributed Delay Approach to Model Delayed Outcomes Involving Loss Mechanism During the Delay Process October 8, 2018 By webdev
Development of a PBPK Model for Docetaxel as a CYP3A Substrate and Accounting for Binding to Multiple Plasma Proteins October 8, 2018 By webdev
Interpretation of Dose-dependent Pharmacokinetics of Ruzasvir Using Both Physiologically-based Pharmacokinetic and Population Pharmacokinetic Modeling Approaches October 8, 2018 By webdev
Development of a Pre-clinical Quantitative Systems Pharmacology Model for E7046, a Novel PGE2 Receptor Type 4 Antagonist for Cancer Immunotherapy October 8, 2018 By webdev
Clinical Trial Simulation (CTS) for a New Rapidly Absorbed Paracetamol Formulation (NP) Development from the Conventional Paracetamol Tablet (CP) October 8, 2018 By webdev
Impact of Free Fatty Acids on Prediction of Unbound Fraction of Cefazolin and Diazepam in Plasma of Full-term Neonates October 8, 2018 By webdev
Application of Feto-maternal Physiologically-based Pharmacokinetic Model to Predict Emtricitabine Concentration During Pregnancy October 8, 2018 By webdev
Modeling Double Peak Phenomenon and In Vitro-In Vivo Correlation (IVIVC) in Pharmacokinetics (PK) for Clinical Trial Simulation (CTS) of Virtual Bioequivalence (BE) Studies October 8, 2018 By webdev
Development of a Population Pharmacokinetic Model for Binimetinib with Subsequent Exposure-response Analyses in NRAS Mutant Melanoma October 8, 2018 By webdev